What is the dose of fluconazole (antifungal) for tinea corporis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluconazole Dosing for Tinea Corporis

For tinea corporis, fluconazole 150 mg once weekly for 2-4 weeks is an effective and recommended dosing regimen. 1, 2

Dosing Options for Tinea Corporis

  • Fluconazole 150 mg once weekly for 2-4 weeks is effective for treating tinea corporis with minimal side effects 1, 2
  • Alternative dosing includes fluconazole 50-100 mg daily for 2-3 weeks 3
  • Once weekly dosing offers better compliance compared to daily regimens 1

Evidence and Efficacy

  • Clinical studies have shown that fluconazole 150 mg once weekly for 4-6 weeks achieved clinical cure in 74% of patients with tinea corporis/cruris 2
  • Total severity scores of clinical symptoms (pruritus, erythema, scaling, burning/pain, vesiculation) were significantly reduced from 7.1 before treatment to 1.5 after treatment with once weekly fluconazole 150 mg 1
  • Mycological cure rates of 78% have been reported with weekly fluconazole regimens 2

Treatment Considerations

  • While topical antifungal agents are first-line for limited tinea corporis, systemic therapy is indicated for extensive disease, multiple sites of infection, or cases unresponsive to topical treatment 3
  • Fluconazole achieves high concentrations in the stratum corneum and has a long elimination half-life, making once weekly dosing effective 1
  • Treatment should continue until clinical and mycological cure is achieved 2

Alternative Systemic Antifungal Options

  • Itraconazole 100 mg daily for 2 weeks or 200 mg daily for 7 days is an effective alternative 3, 4
  • Terbinafine 250 mg daily for 1-2 weeks can also be used, particularly for Trichophyton species infections 3
  • For fluconazole-resistant cases, itraconazole may be preferred, with serum levels >0.2 μg/ml associated with successful treatment outcomes 4

Safety and Monitoring

  • Fluconazole is generally well-tolerated with few side effects reported in clinical trials 1, 2
  • In one study, only 7.5% of patients experienced treatment-related adverse events with fluconazole compared to 12.5% with griseofulvin 2
  • Common side effects may include gastrointestinal symptoms; one study reported a patient with pre-existing gastritis had to discontinue treatment due to abdominal pain 5

Special Considerations

  • For athletes, particularly wrestlers and judo practitioners who have higher rates of tinea corporis (T. corporis gladiatorum), systemic therapy may be particularly beneficial 6
  • In high-risk athletic populations, fluconazole has been used prophylactically (100 mg daily for 3 days) to prevent outbreaks, though this should only be done in consultation with an infectious disease expert 6
  • Treatment failure should prompt investigation of compliance issues, inadequate absorption, or resistant organisms 4

References

Research

Fluconazole in the treatment of tinea corporis and tinea cruris.

Dermatology (Basel, Switzerland), 1998

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Research

[Fluconazole in the treatment of dermatomycoses. Clinical experience].

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.